Regenlab USA Inc.
1 SEC EDGAR filings indexed (CIK 0002084031) across 1 form type.
Filing profile
Regenlab USA Inc. has 1 SEC filing indexed on SecFilingDex, across 1 form type, all filed on September 25, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).
Its most frequent disclosure is the S-1 (IPO registration) with 1 filing — Registration statement filed by a company planning to issue securities to the public for the first time. 1 of these filing was disclosed in the twelve months to September 25, 2026.
Disclosure mix
- 1S-1IPO registration · event-driven (pre-ipo)
Profile derived from 1 indexed filing; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.
All filings
Authoritative source
SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.
Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.